FLEXTRADE-SYSTEMS
FlexTrade Systems (@FlexTrade), a global leader in multi-asset execution and order management systems, and Kepler Cheuvreux (KCx), a leading independent broker, today announced Anima Alternative SGR is live and in production using KCx's new suite of intra-day stock-specific dynamic forecasts and analytics via API.
KCx's API Analytical Suite allows clients to pull data to leverage KCx’s powerful Quantitative Models and Execution observations that are used by KCx's algorithmic trading engine. These include stock-specific forecasts and analytics, such as volume, volatility, and spread forecasts. The offering will also develop further to have pre-trade market impact models and e-cost via machine learning techniques.
With this integration, Anima’s trading team using FlexTRADER EMS can directly stream forecast analytics into the order blotter and display only the columns that suit their specific trading strategies through a customizable and configurable interface. Additionally, with the analytics available within the FlexTRADER EMS order blotter, in combination with FlexAlgoWheel, sophisticated dynamic and arrival rules can be applied by traders using drag-and-drop functionality to automate low-touch orders.
Using KCx’s forecasts, Anima’s traders can create in-flight alerts to guide if an order is not likely to be filled. For example, an alert can be created to notify if a trader's total order quantity required to be filled is more significant than KCx's predicted Aggregated Remaining Volume so alternative sources of liquidity can be sought.
Brian Corcoran, Head of Trading at Anima Alternative, stated: “We are delighted to be one of the first firms to adopt KCx's new analytics suite via our EMS solution, FlexTRADER EMS. We aim to ensure that Anima’s trading team is at the forefront of adopting innovations that deliver the actionable intelligence our teams need to optimize trading decision-making. We are now live and in production with KCx’s forecasts via API, and we look forward to seeing the benefits the innovation can bring.”
Bobbie Port, Head of Electronic Distribution at Kepler Cheuvreux, stated: “We are delighted to roll out the latest phases of our API Analytical suite for client use. Making it available directly within the EMS via API opens a more significant prospect of opportunities for data sharing in the most flexible and agile way. The KCx API provides powerful, easily actionable insights to improve traders' strategies. Integrating KCx Analytical Suite with FlexTRADER EMS assists clients in their search for trading intelligence while leveraging their existing workflows.”
Andy Mahoney, Managing Director, EMEA at FlexTrade, noted: “Our existing clients, like Anima, increasingly want differentiated sources of dynamic, high-fidelity pre-trade analytics to combine with and enrich their trading data. Offerings like KCx’s new analytical suite are a perfect match for FlexTRADER EMS. Our open, flexible design enables clients to bring in the full breadth of forecast data into the EMS and use the analytics in the way that makes the most sense to the individual trader's needs. Combining the predictive analytics with FlexTrade's sophisticated automation and alerting tools is a powerful combination to help traders implement their strategies and course correct if needed."
About FlexTrade Systems:
FlexTrade Systems is a global leader in high performance multi-asset execution management and order management systems for equities, fixed income, foreign exchange, futures, and options. A pioneer in the field, FlexTrade is internationally recognized for introducing FlexTRADER®, the world's first broker-neutral, execution management trading system, which allows clients to completely control and customize their execution workflows through a comprehensive ability to search/access liquidity while maintaining the confidentiality of their trading strategies.
About Kepler Cheuvreux:
Kepler Cheuvreux is a leading independent European financial services company that specialises in Research, Execution, Fixed Income and Credit, Structured Solutions, Corporate Finance, and Asset Management.
The group employs around 600 people and is present in 13 major financial centres in Europe and the US: Amsterdam, Brussels, Frankfurt, Geneva, London, Madrid, Milan, New York, Oslo, Paris, Stockholm, Vienna, and Zurich.
About ANIMA
ANIMA is a leading Italian independent asset management operator, with around €186 billion of assets under management (as of November 2023). A synthesis of different complementary paths and specializations, ANIMA nowadays offers one of the largest range of products and services available on the market. The parent company ANIMA Holding is a public company listed on the Milan Stock Exchange since 2014. In 2020 the group has enlarged through the creation of Anima Alternative Sgr, a company focused on private market investment and fully controlled by ANIMA Holding. In 2023 ANIMA Holding finalized the acquisition of 80% of the capital of Castello SGR, a leading company in the promotion and management of alternative investment products with a specific focus on real estate.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240111104276/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom